The novel treatment of this peptide represents a major breakthrough in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide843188.blog5.net/94832218/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment